AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback

By Yahoo! Finance | Created at 2024-11-22 17:12:38 | Updated at 2024-11-22 22:32:23 6 hours ago
Truth

Access to this page has been denied because we believe you are using automation tools to browse the website.

This may happen as a result of the following:

  • Javascript is disabled or blocked by an extension (ad blockers for example)
  • Your browser does not support cookies

Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.

Reference ID: #f983310c-a8f4-11ef-bc73-712e6f799cd9

Read Entire Article